Preclinical and clinical results in simultaneous radio/chemotherapy of head and neck cancer with paclitaxel;PRAKLINISCHE UND KLINISCHE ERGEBNISSE IN DER SIMULTANEN RADIOCHEMOTHERAPIE VON KOPF-HALS-TUMOREN MIT PACLITAXEL

Strahlentherapie und Onkologie

Volumn 172, Issue SUPPL. 1, 1996, Pages 15-20

  Hoffmann, W ^a   Heinrich, V ^a   Belka, C ^a   Budach, W ^a   Schmidberger, H ^a   Bochtler, H ^a   Rodemann, H P ^a   Bamberg, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT; RADIOSENSITIZING AGENT;

ADULT; CANCER CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MALE; PHASE 1 CLINICAL TRIAL; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CELL CULTURE; DRUG ADMINISTRATION; HEAD AND NECK TUMOR; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RADIATION DOSE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0030008851     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)